News
News of the Researchers and Companies Funded by CQDM
- January 20, 2012
- Medicago announces the development of a vaccine for rabies
- January 16, 2012
- Medicago announces a collaboration with the French organization Cellectis
- December 15, 2011
- CQDM funded projects featured in an innovation article of La Presse
- December 14, 2011
- Harnessing nanotechnology in the fight against cancer - Sylvain Martel
- November 10, 2011
- Medicago holds official ribbon cutting ceremony for its U.S. plant-based vaccine facility
- November 9, 2011
- Sylvain Martel : Miser sur les partenaires stratégiques pour soutenir l'innovation
- October 31, 2011
- Caprion Protéomique: la rentabilité avant les découvertes
- October 28, 2011
- Philip Morris Investments B.V. exercises its pre-emptive right and invests $22.5 million in Medicago
- September 30, 2011
- Medicago announces a $25 million private investment
- September 30, 2011
- Medicago starts its operations in its North Carolina facilities
- July 5, 2011
- Silence radio inquiétant pour la science - Michel Maziade
- June 22, 2011
- Congratulations to Medicago named recipient of 2011 Genesis Entrepreneurship Award presented by BIOQuebec
- June 16, 2011
- Congratulations to Caprion Proteomics for receiving the Innovation Prize awarded by Fondation Armand-Frappier
- June 16, 2011
- Congratulations to Medicago for receiving the 2011 Health Prize awarded by Fondation Armand-Frappier
- June 15, 2011
- Congratulations to Dr Michel Maziade named Chevalier de l'Ordre National du Québec
- June 13, 2011
- Congratulations to Sylvain Martel named "Personnalité La Presse de la semaine".
- May 26, 2011
- Medicago announces research collaboration for the development of a VLP vaccine candidate for the prevention of Ebola
- April 15, 2011
- Medicago announces research collaboration for the development of a non-influenza vaccine candidate with a top 10 global pharmaceutical company
- April 14, 2011
- Congradulations to Medicago Awarded "Best Early-Stage Vaccine Biotechnology Company" in Vaccine Industry Excellence Awards held at the World Vaccine Conference
- February 8, 2011
- Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate
- February 1, 2011
- Medicago reports positive Phase II interim results for its avian flu pandemic vaccine
- November 9, 2010
- Le patriotisme scientifique - Michel Maziade
- October 22, 2010
- CAPRION PROTEOMICS IDENTIFIES PROMISING NEW CANDIDATE BIOMARKERS TO PREDICT RESPONSE TO HEPATITIS C TREATMENT
- August 27, 2010
- Michel Bouvier Receives the Prestigious Michel-Sarrazin Award
- August 25, 2010
- Quebec-based Medicago Inc. recognized as a Canadian Innovation Leader
- June 23, 2010
- Medicago Selected to Negotiate Final Terms with the Defense Advanced Research Projects Agency for Significant Funding Award
- May 14, 2010
- Medicago announces 2010 first quarter financial results
- May 13, 2010
- Medicago announces graduation to the TSX and execution of a $10 million standby equity distribution agreement
- April 23, 2010
- Medicago receives conditional approval to graduate to the TSX
- March 24, 2010
- Medicago announces 2009 fourth quarter and year-end financial results
- March 16, 2010
- Medicago signs MOU with NITT Partners for commercial development of influenza vaccines in Japan
- March 1, 2010
- $300,000 Canadian Institutes of Health Research grant awarded to Medicago, McGill University and the Research Institute of the McGill University Health Centre
- February 17, 2010
- Medicago invited to present at the 6th WHO's meeting on evaluation of pandemic influenza prototype vaccines in clinical trials
- February 5, 2010
- Medicago named to TSX Venture 50
- January 22, 2010
- Caprion Proteomics acquires PPD Biomarkers, LLC from PPDI
- December 21, 2009
- Medicago reports positive Phase I results for its avian flu pandemic vaccine
- November 27, 2009
- Medicago announces 2009 third quarter financial results